Search Within

Timothy Chan

Formats
  1. Journal Article (195)
  2. Meeting Abstract (102)
  3. Book Section (7)
  4. Review (7)
  5. Research Letter (3)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (317)
  2. GSK Faculty (317)
  3. Sloan Kettering Institute Postdocs (143)
  4. Department of Medicine (127)
  5. Solid Tumor Oncology Division (112)
  6. Radiation Oncology, Department of (110)

More Groups

People
  1. Kathryn Beal (68)
  2. Luc Morris (60)
  3. Yoshiya Yamada (51)
  4. Vladimir Makarov (50)
  5. Nadeem Riaz (43)
  6. Fengshen Kuo (42)

More People

Years
  1. 2023 (2)
  2. 2022 (16)
  3. 2021 (15)
  4. 2020 (29)
  5. 2019 (29)
  6. 2018 (31)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (41)
  2. Journal of Clinical Oncology (24)
  3. Neuro-Oncology (19)
  4. Clinical Cancer Research (18)
  5. Cancer Research (16)
  6. Nature Genetics (11)

More Publications

Publishers
  1. Elsevier Inc. (54)
  2. American Association for Cancer Research (44)
  3. Nature Publishing Group (41)
  4. Oxford University Press (32)
  5. American Society of Clinical Oncology (25)
  6. Biomed Central Ltd (18)

More Publishers

Results (317)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy
    Review

    Lee, M.; Samstein, R. M.; Valero, C.; Chan, T. A.; Morris, L. G. T.
    Human Vaccines & Immunotherapeutics (2020)

    Fulltext@MSK | Save
  • Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: A cohort study
    Journal Article

    Sanchez, A.; Furberg, H.; Kuo, F.; Vuong, L.; Ged, Y.; Patil, S.; Ostrovnaya, I.; Petruzella, S.; Reising, A.; Patel, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Tumor cell-intrinsic activity of the RNA receptor RIG-I promotes checkpoint inhibitor-mediated anticancer immunity
    Meeting Abstract

    Heidegger, S.; Wintges, A.; Stritzke, F.; Bek, S.; Steiger, K.; Winter, C.; Rad, R.; van den Brink, M. R. M.; Ruland, J.; Bassermann, F.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • RIG-I activation is critical for responsiveness to checkpoint blockade
    Meeting Abstract

    Heidegger, S.; Wintges, A.; Stritzke, F.; Steiger, K.; Koenig, P. A.; Engleitner, T.; Fischer, J. C.; Makarov, V.; Winter, C.; Rad, R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Therapeutic vulnerabilities and radiosensitization induced by IDH mutant dependent suppression of DNA damage repair in glioma and cholangiocarcinoma
    Meeting Abstract

    Wang, Y.; Wild, A.; Chan, T.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
    Journal Article

    Chowell, D.; Krishna, C.; Pierini, F.; Makarov, V.; Rizvi, N. A.; Kuo, F.; Morris, L. G. T.; Riaz, N.; Lenz, T. L.; Chan, T. A.
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Mechanisms underlying the association between sarcopenia and poor oncologic outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Sanchez, A.; Kuo, F.; Petruzella, S.; Akin, O.; Paris, M.; Russo, P.; Chan, T. A. T.; Mourtzakis, M.; Hakimi, A. A.; Furber, H.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Di Natale, R. G.; Chowell, D.; Makarov, V.; Redzematovic, A.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The impact of PBRM1 mutations on overall survival in greater than 2,100 patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Hakimi, A. A.; Ged, Y.; Flynn, J.; Hoen, D. R.; Di Natale, R. G.; Blum, K. A.; Makarov, V.; Kuo, F.; Carlo, M. I.; Lee, C. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save